Executive Director, Portfolio & Pipeline Strategy

Novartis AG • East Hanover, NJ

76d • $214,900 - $399,100 • Hybrid

About The Position

The Executive Director, Portfolio and Early Pipeline Strategy is responsible for leading a team that is cross-functionally accountable for building the foundation for sustainable and profitable growth of the TA over the 10+ year horizon. Fundamental areas of the job include building forward looking competitive readiness plans, providing input on assets to S&G, GDD and BioMedical Research, partnering with US BD&L and US Market Access, supporting strategic evaluations and initiatives, and leading Early Asset Teams to transition assets from S&G to US Commercial.

Requirements

• Minimum 10 years of commercial experience with multiple functional experience in a pharmaceutical, biotech, healthcare, or consulting environment.
• Recent US Market experience with launch and various product lifecycle stages.
• Experience partnering with Medical Affairs and Global Drug Development to inform strategic choices.
• Highly motivated individual who can work with a high degree of autonomy, in a dynamic environment applying creative problem-solving skills and industry knowledge.
• Possess a portfolio approach and experience uncovering and implementing innovative strategies in a competitive marketplace.
• Ability to be a leader and proactive custodian for consistent competitive readiness excellence.

Responsibilities

• Perform strategic assessments of select competitor activities, including market situation analysis, strategic forecasting, strategic and operational benchmarking, articulation of implications and drive development of a cross-functional competitive response plan in legal and compliant manner.
• Monitor/benchmark strategic plans and key developments of competitors to provide early warning for potential threats and opportunities for successful implementation of prioritized critical initiatives and tactical plans.
• Proactive surveillance of core Disease Area healthcare & macroeconomic environment including policy, regulatory, health technology to identify threats and opportunities relevant to planning initiatives in the US.
• Drive the design and execution of competitive planning initiatives (competitive simulations) for key products subject to significant competitive events.
• Lead strategic planning for lifecycle management (LCM) across the Therapeutic Area portfolio with focus on maximizing the long-term value of our assets.
• Work closely with cross-functional teams including Medical Affairs, Global Drug Development, Strategy & Growth, Novartis Technical Operations, Regulatory, Finance, Supply Chain, Trade and Market Access to ensure realization of LCM priorities.
• Liaison with key cross-functional partners such as Market Access, Medical, BD&L, M&A, Biomedical Research, GDD and S&G teams to develop US go/no-go position on potential asset/company acquisition targets.
• Inform commercial implications to early asset development plans (pre-IDPA), as well as drive development of US-centric commercialization strategy for assets in later stages (pre-FDP).
• Develop center of excellence capabilities within the team.

Benefits

• 401(k) eligibility
• various paid time off benefits, such as vacation, sick time, and parental leave
• sign-on bonus
• restricted stock units
• discretionary awards

What This Job Offers

• Job Type: Full-time
• Career Level: Senior
• Industry: Chemical Manufacturing
• Education Level: Bachelor's degree
• Number of Employees: 5,001-10,000 employees